The expression of additional immune checkpoints in various cancer types has also been described, such as T-cell immunoglobulin and mucin-domain-containing-3 (TIM-3), lymphocyte activation gene-3 (LAG-3), and T-cell immunoglobulin and ITIM domain (TIGIT) [116]. The gene discussed is LAG3; the disease is cancer.